Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
3.700
-0.330 (-8.19%)
At close: Dec 5, 2025, 4:00 PM EST
3.810
+0.110 (2.97%)
After-hours: Dec 5, 2025, 7:55 PM EST
Aethlon Medical Stock Forecast
AEMD's stock price has decreased by -87.91% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Aethlon Medical stock have an average target of 287.5, with a low estimate of 15 and a high estimate of 560. The average target predicts an increase of 7,670.27% from the current stock price of 3.70.
Analyst Consensus: Buy
* Price targets were last updated on Aug 14, 2025.
Analyst Ratings
The average analyst rating for Aethlon Medical stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $15 | Hold | Reiterates | $15 | +305.41% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $15 | Hold | Initiates | $15 | +305.41% | Jul 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $560 | Strong Buy | Reiterates | $560 | +15,035.14% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $560 | Strong Buy | Reiterates | $560 | +15,035.14% | Feb 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $560 | Strong Buy | Reiterates | $560 | +15,035.14% | Jan 30, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-11.38
from -85.77
EPS Next Year
-3.99
from -11.38
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -9.88 | -2.24 | |||
| Avg | -11.38 | -3.99 | |||
| Low | -14.21 | -5.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.